Sangamo rises as FDA accepts rolling submission request for gene therapy

Sangamo Therapeutics (SGMO) added ~9% in the premarket on Friday after the gene therapy developer said that the U.S. FDA ...
FOX 5 Atlanta on MSN

Hoschton woman defies odds, survives stage 4 lung cancer diagnosis

Joanne Cure, 78, survived stage 4 lung cancer after being given two years to live, crediting her faith, determination, and ...
Yahoo! Sports

EGFR Gene Mutation Assay Now Offered by CBLPath

RYE BROOK, NY--(Marketwire - Sep 11, 2012) - CBLPath, a Sonic Healthcare USA laboratory, is pleased to announce the addition of epidermal growth factor receptor (EGFR) mutation analysis to its growing ...
ascopubs.org

Clinicopathologic differences between lung cancer with EGFR gene major (exon 19 deletions and exon 21 L858R) and other minor mutations.

Rates of CNS progression in patients with advanced NSCLC harboring somatic EGFR mutations and treated with gefitinib or erlotinib. Background: The frequency of EGFR gene minor mutations, which are ...
ascopubs.org

Pharmacogenetics of the epidermal growth factor receptor (EGFR) gene in Chinese, Malay and Indian populations

A randomized phase I study of the humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 in subjects with advanced gastrointestinal cancers No significant financial ...
News Medical

Study suggests CT imaging with automated AI system predicts EGFR genotype, identifying mutation status cost-effectively and non-invasively

In a recent study published in The Lancet Regional Health-Southeast Asia, researchers developed an artificial intelligence (AI)-based predictive system (AIPS) model for the early detection of lung ...
Science Daily

Novel therapy shows promise for lung cancer patients with rare EGFR mutation

Researchers report on a multinational, early phase clinical trial evaluating a new targeted therapy for patients with metastatic or unresectable non-small cell lung cancer who have a specific genetic ...